BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26664441)

  • 1. The Relationship between Serum Vitamin D Level and Attention Deficit Hyperactivity Disorder.
    Sharif MR; Madani M; Tabatabaei F; Tabatabaee Z
    Iran J Child Neurol; 2015; 9(4):48-53. PubMed ID: 26664441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of serum vitamin D levels between healthy and ADHD children.
    Massoodi A; Javadian Koutanaei S; Faraz Z; Geraili Z; Zavarmousavi SM
    Caspian J Intern Med; 2023; 14(4):681-686. PubMed ID: 38024166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predict attention deficit hyperactivity disorder? Evidence -based medicine.
    Bener A; Kamal M
    Glob J Health Sci; 2013 Nov; 6(2):47-57. PubMed ID: 24576365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D status in children with attention-deficit-hyperactivity disorder.
    Goksugur SB; Tufan AE; Semiz M; Gunes C; Bekdas M; Tosun M; Demircioglu F
    Pediatr Int; 2014 Aug; 56(4):515-9. PubMed ID: 24417979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum levels of 25-hydroxyvitamin D in children with attention deficit hyperactivity disorder].
    Shang-Guan LL; Zhao YR
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Aug; 17(8):837-40. PubMed ID: 26287349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is high prevalence of vitamin D deficiency a correlate for attention deficit hyperactivity disorder?
    Kamal M; Bener A; Ehlayel MS
    Atten Defic Hyperact Disord; 2014 Jun; 6(2):73-8. PubMed ID: 24610453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D deficiency in school-age Iranian children with attention-deficit/hyperactivity disorder (ADHD) symptoms: A critical comparison with healthy controls.
    Fasihpour B; Moayeri H; Shariat M; Keihanidoust Z; Effatpanah M; Khedmat L
    Child Neuropsychol; 2020 May; 26(4):460-474. PubMed ID: 31514566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Levels of Vitamin A and Vitamin D and Their Association With Symptoms in Children With Attention Deficit Hyperactivity Disorder.
    Li HH; Yue XJ; Wang CX; Feng JY; Wang B; Jia FY
    Front Psychiatry; 2020; 11():599958. PubMed ID: 33329153
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitamin D Deficiency and a Blunted Parathyroid Hormone Response in Children with Attention-Deficit/Hyperactivity Disorder.
    Avcil S; Uysal P; Yilmaz M; Erge D; Demirkaya SK; Eren E
    Clin Lab; 2017 Mar; 63(3):435-443. PubMed ID: 28271675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher prevalence of iron deficiency as strong predictor of attention deficit hyperactivity disorder in children.
    Bener A; Kamal M; Bener H; Bhugra D
    Ann Med Health Sci Res; 2014 Sep; 4(Suppl 3):S291-7. PubMed ID: 25364604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention deficit-hyperactivity disorder is associated with reduced blood pressure and serum vitamin D levels: results from the nationwide German Health Interview and Examination Survey for Children and Adolescents (KiGGS).
    Meyer T; Becker A; Sundermann J; Rothenberger A; Herrmann-Lingen C
    Eur Child Adolesc Psychiatry; 2017 Feb; 26(2):165-175. PubMed ID: 27197525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Vitamin D Supplementation on Attention-Deficit Hyperactivity Disorder in Children.
    Elshorbagy HH; Barseem NF; Abdelghani WE; Suliman HAI; Al-Shokary AH; Abdulsamea SE; Elsadek AE; Abdel Maksoud YH; Nour El Din DMAE
    Ann Pharmacother; 2018 Jul; 52(7):623-631. PubMed ID: 29457493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Vitamin D3 Supplementation on Serum BDNF, Dopamine, and Serotonin in Children with Attention-Deficit/Hyperactivity Disorder.
    Seyedi M; Gholami F; Samadi M; Djalali M; Effatpanah M; Yekaninejad MS; Hashemi R; Abdolahi M; Chamari M; Honarvar NM
    CNS Neurol Disord Drug Targets; 2019; 18(6):496-501. PubMed ID: 31269890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D and vitamin D receptor levels in children with attention-deficit/hyperactivity disorder.
    Sahin N; Altun H; Kurutas EB; Balkan D
    Neuropsychiatr Dis Treat; 2018; 14():581-585. PubMed ID: 29497301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D levels in children and adolescents with attention-deficit hyperactivity disorder (ADHD): a meta-analysis.
    Kotsi E; Kotsi E; Perrea DN
    Atten Defic Hyperact Disord; 2019 Sep; 11(3):221-232. PubMed ID: 30367389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vitamin D treatment in children with attention-deficit hyperactivity disorder.
    Dehbokri N; Noorazar G; Ghaffari A; Mehdizadeh G; Sarbakhsh P; Ghaffary S
    World J Pediatr; 2019 Feb; 15(1):78-84. PubMed ID: 30456564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D Status at Birth and Future Risk of Attention Deficit/Hyperactivity Disorder (ADHD).
    Gustafsson P; Rylander L; Lindh CH; Jönsson BA; Ode A; Olofsson P; Ivarsson SA; Rignell-Hydbom A; Haglund N; Källén K
    PLoS One; 2015; 10(10):e0140164. PubMed ID: 26509435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 25-Hydroxvitamin D concentrations are not lower in children with bronchial asthma, atopic dermatitis, obesity, or attention-deficient/hyperactivity disorder than in healthy children.
    Reinehr T; Langrock C; Hamelmann E; Lücke T; Koerner-Rettberg C; Holtmann M; Legenbauer T; Gest S; Frank M; Schmidt B; Radkowski K; Jöckel KH
    Nutr Res; 2018 Apr; 52():39-47. PubMed ID: 29764626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vitamin D supplementation as adjunctive therapy to methylphenidate on ADHD symptoms: A randomized, double blind, placebo-controlled trial.
    Mohammadpour N; Jazayeri S; Tehrani-Doost M; Djalali M; Hosseini M; Effatpanah M; Davari-Ashtiani R; Karami E
    Nutr Neurosci; 2018 Apr; 21(3):202-209. PubMed ID: 27924679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we predict treatment response in children with ADHD to a vitamin-mineral supplement? An investigation into pre-treatment nutrient serum levels, MTHFR status, clinical correlates and demographic variables.
    Rucklidge JJ; Eggleston MJF; Darling KA; Stevens AJ; Kennedy MA; Frampton CM
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():181-192. PubMed ID: 30217770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.